Cytokinetics CYTK Non Cash Lease Expense
Non Cash Lease Expense at other companies
Other financials
Where this comes from
Reported directly by Cytokinetics in its filing.
Tagged under the XBRL concept cytk:NonCashLeaseExpense.
The official record: Cytokinetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytokinetics's non cash lease expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytokinetics's non cash lease expense?
- Cytokinetics (CYTK) reported non cash lease expense of $1.59M in Q1 2026.
- How has Cytokinetics's non cash lease expense changed year-over-year?
- Cytokinetics's non cash lease expense increased by 28.9% year-over-year, from $1.23M to $1.59M.
- What is the long-term trend for Cytokinetics's non cash lease expense?
- Over 4 years (2021 to 2025), Cytokinetics's non cash lease expense has grown at a -6.4% compound annual growth rate (CAGR), from $7.36M to $5.65M.
- What does non cash lease expense mean?
- The non-cash accounting expense related to long-term lease obligations.
- How do you interpret non cash lease expense?
- Changes reflect shifts in the company's physical footprint and lease accounting treatment.
- How does non cash lease expense compare across companies?
- Standard across all companies reporting under modern lease accounting standards.